Resolvins: A New Approach to Mucosal Healing in Inflammatory Bowel Disease (IBD)

Resolvins are endogenous lipid mediators that promote inflammation resolution and tissue repair without compromising immune function.

Our Technology

Our HEALER technology enables the pharmaceutical development of resolvins as new chemical entities with strong patent protection.

Resolvin Biology

Pro-resolving lipid mediators with robust mucosal healing properties

HEALER™ Platform

Stabilizing resolvins to unlock their potent pharmacology

Intellectual Property

Long-term composition of matter patent protection

"We are committed to creating innovative products that improve the lives of patients suffering from inflammatory bowel disease."

- Frank C. Sciavolino, Ph.D., Founder and Chief Scientific Officer